This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The landscape of medical research is currently in the midst of an exciting transition wherein technology has rapidly become a critical tool for clinicaltrial management and patient data collection. in 2010 to 11.4% in 2020 to enable continuous remote monitoring of real-world patient health data. in 2010 to 11.4%
In 2022, the global market value of patient portals within the clinicalresearch and healthcare industries was estimated to be US $2.9 To learn about the history of these trial technologies and their adoption within the clinicalresearch industry, read more here !
Panelists will answer questions such as: What are the greatest challenges holding patients back from enrolling in trials? I completed a few long-distance rides and raised some funds for research, and in the process, I realized this is what I wanted to do with the rest of my life. I have participated in many trials and studies.
She completed a PhD at Durham University which focused on investigating the mechanisms of cardiotoxicity of cancer therapies using clinically relevant in vitro human models of cardiac physiology paired with novel methodologies to evaluate structural and functional toxicities. 2009 Sep;14(17–18):876–84. Neurotoxicology.
managing partner and director of clinicalresearch, Sierra Eye Associates, clinical associate professor of ophthalmology, University of Nevada
Presentation date and time: The pre-recorded presentation containing slides and audio will be available to AAO 2020 Virtual attendees starting on Wednesday, November 11.
But studies exploring its impact on them remain scant, an analysis of clinicaltrials over the past decade shows. based clinicaltrials investigating interventions for high blood pressure between 2009-2018, just 52 were exclusively in Black people. There hasn’t been much of a change.”
today announced that the first participant has been dosed in TALAPRO-3, a global, randomized, double-blind, placebo-controlled Phase 3 clinicaltrial. The TALAPRO-3 trial will enroll approximately 550 men with DDR-deficient mCSPC across 285 clinicaltrial sites in 28 countries. About TALAPRO-3 Trial.
and Shionogi Limited as shareholders, today announced that an independent data safety monitoring board (DSMB) recommended the early unblinding of the HIV Prevention Trials Network (HPTN) 084 study evaluating the safety and efficacy of investigational, long-acting, injectable cabotegravir for HIV prevention in women.
In an effort to continue this cycle, researchers at UBC also try to get their animals adopted at the end of their studies. According to Weary, the “recognition that the animal is an individual that has a life beyond this particular trial” positively influences their treatment at the hands of researchers.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, the European Organisation for Research and Treatment of Cancer (EORTC) and the European Thoracic Oncology Platform (ETOP) today announced results from the pivotal Phase 3 KEYNOTE-091 trial, also known as EORTC-1416-LCG/ETOP-8-15 – PEARLS. About ETOP.
These advances are reshaping how pharmaceutical and biotechnology companies approach clinicaltrial design, with a focus on patient-centric dosing strategies. This article explores how innovations in precision medicine are reshaping clinicaltrials, followed by a discussion on Project Optimus and its impact on dose optimisation.
2009 Jun;139(6):1242S-1245S. 2009 Oct;23(7):2090-5. 2009 Dec;34(13):2767-78. Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma. based weight loss intervention in adults with obesity: A randomized clinicaltrial. 2009 Apr;52(2):430-6.
mentioned with approval an unappealed trial court ruling that, as to “strict liability,” a cellphone “app was not a product, and thus a products liability theory of recovery was not legally viable.” 2009 WL 1142570, at *8 (Conn. A Florida trial court, in Brookes v. 2009); see also Data Processing Services, Inc.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content